For help on how to get the results you want, see our search tips.
281 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013,
, 
, 
, Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan hydrochloride trihydrate, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,, Revision: 4, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
sorafenib, Carcinoma, Hepatocellular, Carcinoma, Renal Cell
Date of authorisation: 19/07/2006,, Revision: 28, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos) (updated)
daunorubicin hydrochloride / cytarabine, Leukemia, Myeloid, Acute
Date of authorisation: 23/08/2018,, Revision: 2, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Esbriet (updated)
Pirfenidone, Idiopathic Pulmonary Fibrosis
Date of authorisation: 27/02/2011,, Revision: 24, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
lenvatinib mesylate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, 
, Revision: 10, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Empliciti (updated)
Elotuzumab, Multiple Myeloma
Date of authorisation: 11/05/2016,, , Revision: 6, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, , Revision: 17, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Symkevi (updated)
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, , Revision: 3, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
ivacaftor, Cystic Fibrosis
Date of authorisation: 22/07/2012,, , Revision: 20, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Viekirax (updated)
Ombitasvir, paritaprevir, ritonavir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, , Revision: 19, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Zynteglo (updated)
Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019,, , , 
, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vosevi (updated)
Sofosbuvir, velpatasvir, voxilaprevi, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,, , Revision: 6, Authorised, Last updated: 13/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, , Revision: 10, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Imbruvica (updated)
Ibrutinib, Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 21/10/2014,, Revision: 15, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, , Revision: 7, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Cabometyx (updated)
cabozantinib s-malate, Carcinoma, Renal Cell
Date of authorisation: 09/09/2016,, , Revision: 6, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
idebenone, Optic Atrophy, Hereditary, Leber
Date of authorisation: 08/09/2015,, , , Revision: 4, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo (updated)
telotristat etiprate, Carcinoid Tumor, Neuroendocrine Tumors
Date of authorisation: 17/09/2017,, , Revision: 7, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vpriv (updated)
velaglucerase alfa, Gaucher Disease
Date of authorisation: 26/08/2010,, , Revision: 12, Authorised, Last updated: 07/11/2019
-
List item
Human medicine European public assessment report (EPAR): Cometriq (updated)
cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014,, , , Revision: 15, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Sovaldi (updated)
Sofosbuvir, Hepatitis C, Chronic
Date of authorisation: 16/01/2014,, , Revision: 19, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Epclusa (updated)
Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016,, , Revision: 10, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Harvoni (updated)
ledipasvir 90 mg, sofosbuvir 400 mg, Hepatitis C, Chronic
Date of authorisation: 17/11/2014,, , Revision: 18, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Caprelsa (updated)
Vandetanib, Thyroid Neoplasms
Date of authorisation: 16/02/2012,, , Revision: 16, Authorised, Last updated: 05/11/2019